Abiopharma

🔍 Wright Timothy (Executive)

Company: AGENUS INC (AGEN)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 2,448 shares of Deferred Stock Units (Derivative)
  Date: 2026-04-01 | Code: A | equity_swap_involved: false | shares_owned_after: 26,361.26 | transaction_form_type: 4 | Footnotes: F1, F3, F2, F2

Footnotes:

• F1: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.
• F2: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.
• F3: $3.319 per Deferred Stock Unit acquired on April 1, 2026. The price of each Deferred Stock Unit acquired on April 1, 2026 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.